Proposed Collection; 60-Day Comment Request: Request for Human Embryonic Stem Cell Line To Be Approved for Use in NIH Funded Research

Federal Register, Volume 78 Issue 40 (Thursday, February 28, 2013)

Federal Register Volume 78, Number 40 (Thursday, February 28, 2013)

Notices

Pages 13688-13689

From the Federal Register Online via the Government Printing Office www.gpo.gov

FR Doc No: 2013-04669

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

Proposed Collection; 60-Day Comment Request: Request for Human Embryonic Stem Cell Line To Be Approved for Use in NIH Funded Research

SUMMARY: In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Office of Extramural Research (OER), the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.

Written comments and/or suggestions from the public and affected agencies are invited to address one or more of the

Page 13689

following points: (1) Whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) The accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) The quality, utility, and clarity of the information to be collected; and (4) Minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology.

To Submit Comments and For Further Information: To obtain a copy of the data collection plans and instruments, submit comments in writing, or request more information on the proposed project, contact: Dr. Ellen Gadbois, Office of Science Policy, Office of the Director, NIH, Building 1, Room 218, MSC 0166, 9000 Rockville Pike, Bethesda, MD 20892, or call non-toll-free number (301)-496-1454 or Email your request, including your address to: gadboisel@od.nih.gov. Formal requests for additional plans and instruments must be requested in writing.

Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication.

Proposed Collection: Request for Human Embryonic Stem Cell Line to be Approved for Use in NIH Funded Research. OMB No. 0925-0601--

Expiration Date 4/30/2013--Extension--Office of Extramural Research (OER), National Institutes of Health (NIH).

Need and Use of Information Collection: The form is used by applicants to request that human embryonic stem cell lines be approved for use in NIH funded research. Applicants may submit applications at any time.

OMB approval is requested for 3 years. There are no costs to respondents other than their time. The total estimated annualized burden hours are 3,375.

Estimated Annualized Burden Hours

----------------------------------------------------------------------------------------------------------------

Number of Average time

Type of respondent Number of responses per per response Total annual

respondents respondent (in hours) burden hour

----------------------------------------------------------------------------------------------------------------

NIH grantees and others with hESC lines..... 50 3 22.5 3,375

----------------------------------------------------------------------------------------------------------------

Dated: February 21, 2013.

Lawrence A. Tabak,

Deputy Director, National Institutes of Health.

FR Doc. 2013-04669 Filed 2-27-13; 8:45 am

BILLING CODE 4140-01-P

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT